Mogroside VI 5-NH2 TFA Demoxepam is a major metabolite

Demoxepam is a major metabolite of Chlordiazepoxide

ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases

CR4056 dose-dependently reduces mechanical hyperalgesia (effective dose [ED50]=5

and Sodium Tanshinone IIA sulfonate has the potential to perpetrate drug-drug interactions with other CYP3A4 substrates

neither of these two inhibitors showed biologically significant selectivity for nNOS over eNOS

Mogroside VI 5-NH2 TFA Demoxepam is a major metaboliteMogroside VI is a triterpenoid glycoside and a nonsugar sweetener. Mogrosides are sweeter than sucrose. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities. Product information CAS Number: 189307 15 1 Molecular Weight: 1449. 58 Formula: C66H112O34 Chemical Name: (2R,3R,4S,5S,6R) 2 {[(2R,3S,4S,5R,6S) 6 {[(3R,6R) 6 [(1R,3aS,3bS,7S,9aR,9bR,10R,11aR) 7 {[(2R,3R,4S,5S,6R) 4,5 dihydroxy 3 {[(2S,3R,4S,5S,6R) 3,4,5 trihydroxy 6